Systemic immunity in cancer

Kamir J. Hiam-Galvez; Breanna M. Allen; Matthew H. Spitzer

doi:10.1038/s41568-021-00347-z

Keywords

Immune systemImmunotherapyImmunityImmunologyCancer immunotherapyCancerTumor microenvironmentBiologyDiseaseMedicineInternal medicine

Affiliated Institutions

University of California, San Francisco US

Related Publications

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

Bagher Farhood , Masoud Najafi , Keywan Mortezaee

Abstract CD8 + cytotoxic T lymphocytes (CTLs) are preferred immune cells for targeting cancer. During cancer progression, CTLs encounter dysfunction and exhaustion due to immune...

2018 Journal of Cellular Physiology 1662 citations

Cancer Immunotherapy Comes of Age

Suzanne L. Topalian , George J. Weiner , Drew M. Pardoll

Cancer immunotherapy comprises a variety of treatment approaches, incorporating the tremendous specificity of the adaptive immune system (T cells and antibodies) as well as the ...

2011 Journal of Clinical Oncology 572 citations

Coinhibitory Pathways in Immunotherapy for Cancer

Susanne H.C. Baumeister , Gordon J. Freeman , Glenn Dranoff +1 more

The immune system is capable of recognizing tumors and eliminates many early malignant cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is im...

2016 Annual Review of Immunology 891 citations

Enhancement of Antitumor Immunity by CTLA-4 Blockade

Dana R. Leach , Matthew F. Krummel , James P. Allison

One reason for the poor immunogenicity of many tumors may be that they cannot provide signals for CD28-mediated costimulation necessary to fully activate T cells. It has recentl...

1996 Science 3810 citations

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

Changyu Wang , Kent Thudium , Minhua Han +15 more

Abstract The programmed death-1 (PD-1) receptor serves as an immunologic checkpoint, limiting bystander tissue damage and preventing the development of autoimmunity during infla...

2014 Cancer Immunology Research 580 citations

Publication Info

Year: 2021
Type: review
Volume: 21
Issue: 6
Pages: 345-359
Citations: 1223
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Systemic immunity in cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1223

OpenAlex

Cite This

APA Style

                            
                                    Kamir J. Hiam-Galvez, 
                                
                                    Breanna M. Allen, 
                                
                                    Matthew H. Spitzer
                                
                            (2021). 
                            Systemic immunity in cancer. 
                            Nature reviews. Cancer
                            , 21
                            (6)
                            , 345-359.
                            https://doi.org/10.1038/s41568-021-00347-z

Identifiers

DOI: 10.1038/s41568-021-00347-z

Systemic immunity in cancer

Keywords

Affiliated Institutions

Related Publications

CD8<sup>+</sup> cytotoxic T lymphocytes in cancer immunotherapy: A review

Cancer Immunotherapy Comes of Age

Coinhibitory Pathways in Immunotherapy for Cancer

Enhancement of Antitumor Immunity by CTLA-4 Blockade

<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates

Publication Info

External Links

Social Impact

Citation Metrics

Cite This

Identifiers